SEC Form 4 · accession 0001144204-17-018993
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Strobeck
Director
Period of report
Apr 1, 2017
Accepted (ET)
Apr 4, 2017 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $24.20 | Apr 1, 2017 | A | 11,721 | A | — | Apr 1, 2027 | Common Stock | 11,721 | 11,721 | D |
Explanation of responses
- F1The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2017.
- F2The total number of stock options held by the reporting person was previously aggregated in Table II of the reporting person's previous Form 4s. The number of stock options reported on this Form 4 reflects only the number of stock options of the class reported herein.